Advanced Diagnostic & Monitoring Systems + Non-Narcotic Chronic Pain Solutions

No side effects

Safe alternative to medications.

Affordable

Low-cost treatment access.

Effective

Controls chronic disease pain.

Convenient

Small wearable behind the ear.

Advanced ANS Neurostimulation

Our Story

Engineering hope through neuroscience

NEUROSTIMULATION MEDTECH provides unique solutions that combine our exclusive research on the autonomic nervous system (ANS) and insights regarding its involvement in chronic pain treatment.

We develop, manufacture and distribute products that provide the highest fidelity representations of the ANS. The ANS is increasingly recognized as the bodily system behind wellness and fitness. Our products meet the growing interest in being able to accurately measure heart rate variability (HRV).

Our auricular neurostimulation device is being used for chronic pain treatment, drug detoxification, and post-operative pain management. This was among the first wearable devices to use all the key technologies of the wearable industry including adhesives, batteries, processors and sensors.

Our Mission

To deliver safe, effective and affordable neurostimulation technology that empowers clinicians and restores quality of life for patients living with chronic, disabling conditions.

Our Vision

A world where the autonomic nervous system can be monitored and modulated as routinely as the heart — making non-invasive neuromodulation a first-line therapy worldwide.

Mission and Vision in Practice

A balanced autonomic nervous system: Improving and preserving health and wellness is a matter of reducing autonomic dysfunction and ensuring that the ANS is in balance. The foundation of being able to ensure a balanced system is having an accurate measurement to show changes. We have developed the most accurate technique to measure the ANS. And, we are working to make this more accessible so that it can be used not only in a doctor’s office but also in daily life by an individual at home. We are committed to implementing product development and marketing programs to achieve this.

Effective and affordable solutions for pain treatment: It has been demonstrated that vagal stimulation is appropriate for treating pain. We are working on showing that vagal stimulation via the ear achieves the same effect as invasive vagal stimulation elsewhere, which will make this minimally invasive treatment applicable to a much wider range of patients.

The Autonomic Nervous System (ANS) is fundamental to everything we do. We are focused on developing and marketing diagnostic products that measure the ANS and reduce dysfunction while developing and marketing treatment products that provide vagal stimulation.

Two Decades of Autonomic Innovation

2003

2010

2015

2020

Current

Founded with a focus on heart-rate variability and ANS monitoring research.

Launched the Ansiscope — a clinical-grade ANS analysis platform.

Introduced wearable percutaneous electrical neurostimulator devices for chronic pain.

Expanded into opioid-withdrawal treatment programs in the US and Europe.

Devices used in hospitals, pain clinics and addiction programs across 20+ countries.

Our Research and Publications

Stay ahead with Insights

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Wearable Device Available to Treat Opioid Addiction without Narcotics

meenaxi.badola@justwords.in
May 13, 2026

San Mateo, Ca – Patients going through the difficult opioid withdrawal process are often treated

Non-narcotic pain management after shoulder surgery

meenaxi.badola@justwords.in
May 13, 2026

Background On a trip in May 2019 to visit her sister and her family (nephews,

Choosing a Customer Relationship Management System for your organization

meenaxi.badola@justwords.in
May 7, 2026

What CRM are you using and have you set it up completely? The two most

FDA Clears DyAnsys Neurostiniulation Device Priniary Relief to Treat Post-Cardiac Surgery Pain

meenaxi.badola@justwords.in
September 22, 2022

PALO ALTO, Calif., Sept. 22, 2022 /PR Newswire/ — DyAnsys, Inc., has announced that Primary

FDA Clears DyAnsys Neurostimulation Device First Relief to treat Diabetic Neuropathic Pain

meenaxi.badola@justwords.in
August 29, 2022

PALO ALTO, Calif., July 14, 2022 /PRNewswire/ — First Relief, a PENS (percutaneous electrical neurostimulation)

Non-narcotic Alleviation of Pain in Rheumatoid Arthritis

meenaxi.badola@justwords.in
February 10, 2020

M.Robin October 2019 Rheumatoid arthritis (RA) is an autoimmune disease that most commonly affects the